Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00142
Species: Homo sapiens
Position : chr8:12891950-12892610
Year: 2024
Title: Selective Enhancer Gain of Function Deregulates MYC Expression in Multiple Myeloma
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: Multiple myeloma
PMID:  39312195
MONDO: MONDO:0009696
Tissue: Bone marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: ANBL6
CVCL ID: CVCL_5425
Cell Type: multiple myeloma cell line
Cell Ontology ID: CL:0007783
Experiment Type: dCas9-KRAB CRISPRi, CRISPR-Cas9 binding site knockout, dual-luciferase reporter assay, Micro-C chromatin contact validation
High Throughput Method: H3K27ac ChIP-seq, ATAC-seq, WGS, RNA-seq, pooled CRISPRi tiling screen
Low Throughput Method: qRT-PCR, sgRNA lentiviral transduction, dual-luciferase quantification
About Target Gene
Target gene : MYC
About TF
TF name : MAF
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
MAF AP-1 transcription factor network pid 71
MAF C-MYB transcription factor network pid 87
MAF Calcineurin-regulated NFAT-dependent transcription in lymphocytes pid 50
MAF Kaposi sarcoma-associated herpesvirus mirtarbase 13
MAF Hs_TYROBP_Causal_Network_WP3945_90843 wikipathways 54
Enhancer Associated Network
Overlapping Enhancers (hg38) 2 found
Enhancer ID Position Tissue Cell Disease
E_00141 chr8:12891950-12892610 Bone marrow multiple myeloma cell line Multiple myeloma
E_00143 chr8:12891950-12892610 Bone marrow multiple myeloma cell line Multiple myeloma
Expression of Target Genes for the Enhancer